(Q34548938)

English

Double-blind study to evaluate efficacy and safety of meloxicam 7.5 mg and 15 mg versus mefenamic acid 1500 mg in the treatment of primary dysmenorrhea

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 August 2017

Double-blind study to evaluate efficacy and safety of meloxicam 7.5 mg and 15 mg versus mefenamic acid 1500 mg in the treatment of primary dysmenorrhea (English)

1 reference

Europe PubMed Central

3 August 2017

1 reference

based on heuristic

inferred from title

author name string

Nilson Roberto de Mello

1

1 reference

Europe PubMed Central

3 August 2017

Edmund Chada Baracat

2

1 reference

Europe PubMed Central

3 August 2017

Geraldez Tomaz

3

1 reference

Europe PubMed Central

3 August 2017

Aloísio José Bedone

4

1 reference

Europe PubMed Central

3 August 2017

Aroldo Camargos

5

1 reference

Europe PubMed Central

3 August 2017

Ione Cristina Barbosa

6

1 reference

Europe PubMed Central

3 August 2017

Rosival Nassar de Souza

7

1 reference

Europe PubMed Central

3 August 2017

Demetrio Ortega Rumi

8

1 reference

Europe PubMed Central

3 August 2017

Felix Octavio Martinez Alcala

9

1 reference

Europe PubMed Central

3 August 2017

Jorge Antonio Aldrete Velasco

10

1 reference

Europe PubMed Central

3 August 2017

Roberto Jose Risco Cortes

11

1 reference

Europe PubMed Central

3 August 2017

publication date

1 July 2004

1 reference

Europe PubMed Central

3 August 2017

Acta Obstetricia et Gynecologica Scandinavica

1 reference

Europe PubMed Central

3 August 2017

83

1 reference

Europe PubMed Central

3 August 2017

7

1 reference

Europe PubMed Central

3 August 2017

667-673

1 reference

Europe PubMed Central

3 August 2017

Determination of menstrual prostaglandin levels in non-dysmenorrheic and dysmenorrheic subjects

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-6349.2004.00433.X

21 January 2018

A double-blind, placebo-controlled study comparing three single-dose regimens of piroxicam with ibuprofen in patients with primary dysmenorrhea

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-6349.2004.00433.X

21 January 2018

Prostaglandins, indomethacin and dysmenorrhea

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-6349.2004.00433.X

21 January 2018

The effect of naproxen-sodium on the intrauterine pressure and menstrual pain of dysmenorrheic patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-6349.2004.00433.X

21 January 2018

Prostaglandin endoperoxide synthase: regulation of enzyme expression

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-6349.2004.00433.X

21 January 2018

Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-6349.2004.00433.X

21 January 2018

Multiple female reproductive failures in cyclooxygenase 2-deficient mice.

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-6349.2004.00433.X

21 January 2018

Pharmacology of meloxicam, a new non-steroidal anti-inflammatory drug with an improved safety profile through preferential inhibition of COX-2.

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-6349.2004.00433.X

21 January 2018

Towards a better aspirin

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-6349.2004.00433.X

21 January 2018

Identifiers

10.1111/J.0001-6349.2004.00433.X

1 reference

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

3 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34548938&oldid=1645634412"